NCT06254404View on ClinicalTrials.gov

Impact of Protamine Dose Reduction on Platelet Aggregation After Extracorporeal Circulation for Minimally Invasive Aortic Valve Replacement Surgery

NANot yet recruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

March 15, 2024

Primary Completion Date

October 1, 2024

Study Completion Date

October 1, 2024

Conditions
Protamine DoseProtamine Adverse Reaction
Interventions
DRUG

Low dose protamine

Administration of 70% of the normal dose of protamine

All Listed Sponsors
lead

University of Liege

OTHER

NCT06254404 - Impact of Protamine Dose Reduction on Platelet Aggregation After Extracorporeal Circulation for Minimally Invasive Aortic Valve Replacement Surgery | Biotech Hunter | Biotech Hunter